Clinical Trials Directory

Trials / Completed

CompletedNCT06972134

Synergistic Effects of Natural Oils and Herbal Extracts on Cholesterol Gallstone Dissolution: In Vitro Comparison With Rowachol®

Synergistic Effects of Sesame Oil, Extra Virgin Olive Oil, Psyllium Extract, and Dandelion Extract on Cholesterol Gallstone Dissolution: An In Vitro Comparative Study Against Rowachol®

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
University of Duhok · Academic / Other
Sex
All
Age
40 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Objective: This study aims to evaluate the effectiveness of a natural mixture (sesame oil, extra virgin olive oil, psyllium extract, and dandelion extract) in dissolving cholesterol gallstones compared to the standard medication, Rowachol®. Methods: In laboratory experiments, 70 cholesterol gallstones obtained from 55 patients were divided into seven groups. Each group was treated with different combinations of the natural ingredients or Rowachol®. The stones were monitored for 144 hours to measure dissolution rate and cholesterol release.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSesame Oil (SO) at 100 mg/mL in dissolving fluid.Pure Sesamum indicum oil (cold-pressed, unrefined) dissolved in BioIVT bile juice at 100 mg/mL. Prepared by homogenization (30 min, 37°C). Used as monotherapy.
DIETARY_SUPPLEMENTExtra Virgin Olive Oil (EVOO) at 100 mg/mL in dissolving fluid.Pure Olea europaea oil (first cold-pressed, acidity ≤0.8%) dissolved in BioIVT bile juice at 100 mg/mL. Prepared by vortex mixing (15 min, 25°C). Used as monotherapy.
DIETARY_SUPPLEMENT50% Sesame Oil (SO) + 50% Extra Virgin Olive Oil (EVOO).A 1:1 (v/v) blend of Sesamum indicum oil (AIU-BC-618-1) and Olea europaea oil (AIU-BC-618-2). Final concentration: 100 mg/mL in BioIVT bile juice. Prepared by mechanical stirring (1 hr, 40°C).
DIETARY_SUPPLEMENT50% Psyllium Extract (PE) + 50% Oil Blend (50% SO + 50% EVOO).50% Plantago ovata mucilage extract (aqueous extraction, 65°C) + 50% AIU-BC-618-3 (SO+EVOO blend). Final concentration: 100 mg/mL in BioIVT bile juice. Prepared by sonication (20 min).
DIETARY_SUPPLEMENTPlantago ovata extract (AIU-BC-618-4) + AIU-BC-618-350% Taraxacum officinale root extract (ethanol-water extraction, 70°C) + 50% AIU-BC-618-3 (SO+EVOO blend). Final concentration: 100 mg/mL in BioIVT bile juice. Prepared by magnetic stirring (30 min, 50°C).
DIETARY_SUPPLEMENT50% Herbal Extract (25% PE + 25% DE) + 50% Oil Blend (25% SO + 25% EVOO).25% Plantago ovata extract (AIU-BC-618-4) + 25% Taraxacum officinale extract (AIU-BC-618-5) + 25% SO (AIU-BC-618-1) + 25% EVOO (AIU-BC-618-2). Final concentration: 100 mg/mL in BioIVT bile juice. Prepared by homogenization (45 min, 37°C).
DRUGDrug: Rowachol® (terpene extract) at 100 mg/mL in dissolving fluid.25% Plantago ovata extract (AIU-BC-618-4) + 25% Taraxacum officinale extract (AIU-BC-618-5) + 25% SO (AIU-BC-618-1) + 25% EVOO (AIU-BC-618-2). Final concentration: 100 mg/mL in BioIVT bile juice. Prepared by homogenization (45 min, 37°C).

Timeline

Start date
2023-12-15
Primary completion
2024-05-17
Completion
2024-08-28
First posted
2025-05-14
Last updated
2025-05-18

Locations

1 site across 1 country: Syria

Source: ClinicalTrials.gov record NCT06972134. Inclusion in this directory is not an endorsement.